0001493152-17-004195.txt : 20170419
0001493152-17-004195.hdr.sgml : 20170419
20170419204929
ACCESSION NUMBER: 0001493152-17-004195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170417
FILED AS OF DATE: 20170419
DATE AS OF CHANGE: 20170419
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VBI VACCINES INC.
CENTRAL INDEX KEY: 0000704159
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930589534
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6178303031
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: PAULSON CAPITAL (DELAWARE) CORP.
DATE OF NAME CHANGE: 20140326
FORMER COMPANY:
FORMER CONFORMED NAME: PAULSON CAPITAL CORP
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeWilde Michel
CENTRAL INDEX KEY: 0001615614
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18188
FILM NUMBER: 17771151
MAIL ADDRESS:
STREET 1: C/O VBI VACCINES INC.
STREET 2: 222 THIRD STREET, STE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4.xml
X0306
4
2017-04-17
0
0000704159
VBI VACCINES INC.
VBIV
0001615614
DeWilde Michel
C/O VBI VACCINES INC.
222 THIRD STREET, STE 2241
CAMBRIDGE
MA
02142
1
0
0
0
Option (Right to Buy Common Shares)
3.79
2017-04-17
4
A
0
12500
0
A
2027-01-26
Common Shares
12500
12500
D
The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated April 17, 2017 (the "Option Agreement"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date.
The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.
/s/ Michel DeWilde
2017-04-19